Creative Planning Increases Position in Balchem Co. (NASDAQ:BCPC)

Creative Planning boosted its position in Balchem Co. (NASDAQ:BCPC) by 33.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,777 shares of the basic materials company’s stock after buying an additional 2,449 shares during the period. Creative Planning’s holdings in Balchem were worth $1,721,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in BCPC. Vanguard Group Inc. raised its position in Balchem by 3.8% during the first quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock worth $609,873,000 after acquiring an additional 144,423 shares during the last quarter. Conestoga Capital Advisors LLC grew its position in Balchem by 2.7% in the second quarter. Conestoga Capital Advisors LLC now owns 1,155,209 shares of the basic materials company’s stock valued at $177,844,000 after acquiring an additional 29,825 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Balchem by 0.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after buying an additional 5,977 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Balchem by 1.2% in the second quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company’s stock worth $42,717,000 after acquiring an additional 3,279 shares in the last quarter. Finally, William Blair Investment Management LLC raised its position in shares of Balchem by 8.4% in the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock valued at $35,998,000 after purchasing an additional 18,104 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on BCPC. HC Wainwright increased their price target on shares of Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday.

Balchem Stock Down 0.9 %

BCPC stock opened at $169.26 on Wednesday. The firm’s 50-day moving average is $171.75 and its two-hundred day moving average is $162.70. The company has a market capitalization of $5.49 billion, a price-to-earnings ratio of 47.81, a price-to-earnings-growth ratio of 5.43 and a beta of 0.65. Balchem Co. has a 52 week low of $113.90 and a 52 week high of $186.03. The company has a current ratio of 2.83, a quick ratio of 1.79 and a debt-to-equity ratio of 0.26.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.